TY - JOUR
T1 - Switching from baricitinib to dupilumab as an advanced-line treatment in pediatric patients with atopic dermatitis
T2 - a retrospective cohort study
AU - Ollech, Ayelet
AU - Cohen-Barak, Eran
AU - Horev, Amir
AU - Bar-Ilan, Efrat
AU - Greenberger, Shoshana
PY - 2024/7
Y1 - 2024/7
KW - atopic dermatitis
KW - biological treatment
KW - dupilumab baricitinib
KW - JAK inhibitors
KW - pediatric patients
KW - systemic treatment
KW - Severity of Illness Index
KW - Humans
KW - Child, Preschool
KW - Male
KW - Pyrazoles/administration & dosage
KW - Treatment Outcome
KW - Purines/administration & dosage
KW - Dermatitis, Atopic/drug therapy
KW - Dermatologic Agents/therapeutic use
KW - Sulfonamides/therapeutic use
KW - Antibodies, Monoclonal, Humanized/administration & dosage
KW - Adolescent
KW - Female
KW - Retrospective Studies
KW - Azetidines/therapeutic use
KW - Drug Substitution
KW - Child
UR - http://www.scopus.com/inward/record.url?scp=85193356029&partnerID=8YFLogxK
U2 - 10.1111/ijd.17198
DO - 10.1111/ijd.17198
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???
C2 - 38751334
AN - SCOPUS:85193356029
SN - 0011-9059
VL - 63
SP - e130-e132
JO - International Journal of Dermatology
JF - International Journal of Dermatology
IS - 7
ER -